Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.
Sherif, Iman O; Al-Mutabagani, Laila A; Alnakhli, Anwar M; Sobh, Mohamed A; Mohammed, Hoda E.
Exp Biol Med (Maywood)
; 240(12): 1572-9, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25825359
Utilité des examens complémentaires dans le bilan initial d'une insuffisance rénale aiguë.
[Biomarkers of cardiac surgery-associated acute kidney injury: a narrative review].
Adipose-derived mesenchymal stem cells therapy for acute kidney injury induced by ischemia-reperfusion in a rat model.
Creatinine-based definitions: from baseline creatinine to serum creatinine adjustment in intensive care.
Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.
Predictive Factors Upon Discontinuation of Renal Replacement Therapy for Long-Term Chronic Dialysis and Death in Acute Kidney Injury Patients.
The definition of acute kidney injury - Authors' reply.
Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation.
Tidal versus other forms of peritoneal dialysis for acute kidney injury.
Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease.